Last reviewed · How we verify
NCT05350384
An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy
trial testing Methylprednisolone in Purtscher Retinopathy in 1 participant. Completed in 1 November 2021.
31 July 2021
Quick facts
| Lead sponsor | University of Catania |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 18 June 2021 |
| Primary completion | 31 July 2021 |
| Estimated completion | 1 November 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Methylprednisolone (methylprednisolone) — full drug profile →
Conditions studied
- Purtscher Retinopathy — all drugs for Purtscher Retinopathy →
- Pancreatic Cancer — all drugs for Pancreatic Cancer →
Sponsor
University of Catania
Who can join
Eligibility, male only, with Purtscher Retinopathy or Pancreatic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
AN UNUSUAL ASSOCIATION BETWEEN PANCREATIC CANCER AND PURTSCHER-LIKE RETINOPATHY
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An unusual association between pancreatic cancer and Purtscher-like retinopathy: Presentation of a unique case.
Intagliata E, Giugno S, Vizzini C, Cacciola RR, et al · · 2022 · cited 1× · PMID 35753234 · DOI 10.1016/j.ijscr.2022.107338
Verify or expand the search:
- PubMed search for NCT05350384
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Methylprednisolone
Trials testing the same drug.
- NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
- NCT07455396 — Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Ped · Phase 2 · not yet recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07357935 — Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced · Phase 1, PHASE2 · not yet recruiting
- NCT07265258 — A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease · Phase 4 · not yet recruiting
Other University of Catania trials
Trials by the same sponsor.
- NCT07455643 — Closed-loop Response to Unannounced Mixed and Carbohydrates-rich Breakfasts · NA · completed
- NCT06831487 — Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in Characterization of Gingival Systemic Health, G · NA · enrolling by invitation
- NCT06725095 — Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis · NA · enrolling by invitation
- NCT06020937 — Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study · not yet recruiting
- NCT07300657 — Impact of an AI-Based Chatbot on Implant Patient Management: RCT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05350384 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Catania
- Last refreshed: 28 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05350384.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing